<?xml version="1.0" encoding="UTF-8"?>
<bibdataset xsi:schemaLocation="http://www.elsevier.com/xml/ani/ani http://www.elsevier.com/xml/ani/ani512.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns="http://www.elsevier.com/xml/ani/ani">
<item>
<ait:process-info>
<ait:date-delivered year="2016" month="06" day="15"/>
<ait:date-sort year="2015" month="01" day="01"/>
<ait:status type="core" state="new" stage="S300"/>
</ait:process-info>
<bibrecord>
<item-info>
<copyright type="Elsevier">Copyright 2016 Elsevier B.V., All rights reserved.</copyright>
<itemidlist>
<ce:doi>10.3233/978-1-61499-564-7-975</ce:doi>
<itemid idtype="PUI">15204055</itemid>
<itemid idtype="CAR-ID">643592588</itemid>
<itemid idtype="NURSNG">2016002332</itemid>
<itemid idtype="SNEMB">2016001390</itemid>
</itemidlist>
<history>
<date-created timestamp="BST 05:16:11" year="2016" month="01" day="04"/>
</history>
<dbcollection>NURSNG</dbcollection>
<dbcollection>SNEMB</dbcollection>
</item-info>
<head>
<citation-info>
<citation-type code="cp"/>
<citation-language xml:lang="eng"/>
<abstract-language xml:lang="eng"/>
<author-keywords>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
</author-keywords>
</citation-info>
<citation-title>
<titletext xml:lang="eng" original="y">the</titletext>
</citation-title>
<author-group>
<author seq="1" type="auth">
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</author>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
</author-group>
<author-group>
<author seq="2" type="auth">
<ce:initials>Y.</ce:initials>
<ce:indexed-name>Nohara Y.</ce:indexed-name>
<ce:surname>Nohara</ce:surname>
<ce:given-name>Yasunobu</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Medical Information Center</organization>
<organization>Kyushu University Hospital</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<author-group>
<author seq="3" type="auth">
<ce:initials>P.</ce:initials>
<ce:indexed-name>Ghosh P.</ce:indexed-name>
<ce:surname>Ghosh</ce:surname>
<ce:given-name>Partha</ce:given-name>
</author>
<author seq="4" type="auth">
<ce:initials>R.</ce:initials>
<ce:indexed-name>Islam Maruf R.</ce:indexed-name>
<ce:surname>Islam Maruf</ce:surname>
<ce:given-name>Rafiqul</ce:given-name>
</author>
<affiliation country="bgd">
<organization>Grameen Communications</organization>
<city>Dhaka</city>
</affiliation>
</author-group>
<author-group>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Graduate School of Information Science and Electrical Engineering</organization>
<organization>Kyushu University</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<correspondence>
<person>
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
</person>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</correspondence>
<abstracts>
<abstract original="y">
<publishercopyright>Â© 2015 IMIA and IOS Press.</publishercopyright>
<ce:para>Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors? It is well documented that atypical antipsychotics have an influence on cognitive function in patients with schizophrenia, although the neurochemical basis for this effect is not well understood. One suggestion is that the effects are exerted through action on 5HT-2A receptors, which leads to changes in the level of dopamine in the prefrontal cortex. The following study explored this hypothesis by comparing the cognitive effects of the atypical antipsychotics which have a high affinity for 5HT-2A receptors, with those that have little or no affinity to these receptors. Forty-four patients with a DSM-IV diagnosis of schizophrenia were recruited within 6 weeks of starting one of the atypical antipsychotics: clozapine, olanzapine, risperidone, quetiapine, or amisulpride. The patients were divided into two groups according to the 5HT-2A affinity of the individual medications (high 5HT-2A affinity--clozapine, olanzapine, risperidone vs. low 5HT-2A affinity--quetiapine, amisulpride). Patients were tested on a broad range of neuropsychological measures after 9 months and 18 months of treatment. The high 5HT-2A affinity group showed a decrement in performance on tests of visual recognition memory and planning ability. In contrast, the low-5HT-2A affinity group showed improvements on these measures in addition to others. The 5HT-2A affinity of the atypical antipsychotics is an important determinant of their cognitive effects.</ce:para>
</abstract>
</abstracts>
<source type="k" country="nld">
<sourcetitle>Studies in Health Technology and Informatics</sourcetitle>
<sourcetitle-abbrev>Stud. Health Technol. Informatics</sourcetitle-abbrev>
<translated-sourcetitle xml:lang="eng">Studies in Health Technology and Informatics</translated-sourcetitle>
<issuetitle>MEDINFO 2015: eHealth-Enabled Health - Proceedings of the 15th World Congress on Health and Biomedical Informatics</issuetitle>
<issn type="electronic">18798365</issn>
<issn type="print">09269630</issn>
<isbn type="electronic" length="13" level="volume">9781614995630</isbn>
<volisspag>
<voliss volume="216"/>
<pagerange first="975"/>
</volisspag>
<publicationyear first="2015"/>
<publicationdate>
<year>2015</year>
</publicationdate>
<website>
<ce:e-address>http://www.iospress.nl/bookserie/studies-in-health-technology-and-informatics/</ce:e-address>
</website>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Georgiou A.</ce:indexed-name>
<ce:surname>Georgiou</ce:surname>
<ce:given-name>Andrew</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>I.N.</ce:initials>
<ce:indexed-name>Sarkar I.N.</ce:indexed-name>
<ce:degrees>Dr.</ce:degrees>
<ce:surname>Sarkar</ce:surname>
<ce:given-name>Indra Neil</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>P.M.</ce:initials>
<ce:indexed-name>de Azevedo Marques P.M.</ce:indexed-name>
<ce:surname>de Azevedo Marques</ce:surname>
<ce:given-name>Paulo Mazzoncini</ce:given-name>
</contributor>
</contributor-group>
<publisher>
<publishername>IOS Press</publishername>
<affiliation country="nld">
<address-part>Nieuwe Hemweg 6B</address-part>
<city>Amsterdam</city>
<postal-code>1013 BG</postal-code>
</affiliation>
</publisher>
<additional-srcinfo>
<conferenceinfo>
<confevent>
<confname>15th World Congress on Health and Biomedical Informatics, MEDINFO 2015</confname>
<confnumber>15</confnumber>
<conftheme>eHealth-Enabled Health</conftheme>
<confseriestitle>World Congress on Health and Biomedical Informatics</confseriestitle>
<conflocation country="bra">
<city>Sao Paulo</city>
</conflocation>
<confdate>
<startdate year="2015" month="08" day="19"/>
<enddate year="2015" month="08" day="23"/>
</confdate>
<confcode>116956</confcode>
<confsponsors complete="n">
<confsponsor></confsponsor>
</confsponsors>
</confevent>
</conferenceinfo>
</additional-srcinfo>
</source>
<enhancement>
<classificationgroup>
<classifications type="ASJC">
<classification>2204</classification>
<classification>2718</classification>
<classification>3605</classification>
</classifications>
</classificationgroup>
</enhancement>
</head>
<tail>
<bibliography refcount="1"/>
</tail>
</bibrecord>
</item>
</bibdataset>
